Feature image

What's New

Prescriber Update 47(1) March 2026

We've published the latest issue of Prescriber Update.

This issue contains important safety information about gynaecomastia with medicines, Fournier's gangrene with empagliflozin, zoledronic acid use in elderly patients, and more.

Prescriber Update 47(1) March 2026

News and Events

Date Type Title
11/3/2026ConsultationConsultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984
11/3/2026CommitteesAgenda for the 76th Medicines Classification Committee meeting
5/3/2026PublicationsPrescriber Update Vol. 47. No. 1 - March 2026
2/3/2026ConsultationOutcome of the consultation on the proposal for the package labelling of topical corticosteroids to state their potency
20/2/2026ConsultationVerification Pathway for New Medicine Applications
16/2/2026MedicinesPolicy Statements - Declaring excipient(s) with known effect in data sheets
26/1/2026Monitoring CommunicationM² Logo Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide, semaglutide, tirzepatide) and acute persistent visual loss
15/1/2026NoticesUpdated Clinical Trial Guidelines
15/1/2026ConsultationOutcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials
15/1/2026ConsultationProposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications